NZ,
that's the really frightening part...they have marketed themselves way more than any other biotech
No-one is interested in their message and that has to do with who is delivering the message and how it's being delivered
Ann: CMO Appointment and Clinical Trials Update, page-126
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
-0.015(4.05%) |
Mkt cap ! $25.68M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.0¢ | 35.3¢ | $432.0K | 1.193M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 260427 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.5¢ | 15171 | 3 |
View Market Depth
| Last trade - 12.59pm 05/12/2024 (20 minute delay) ? |
| DXB (ASX) Chart |